Bank of New York Mellon Corp - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 348 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$2,120,825
-4.2%
137,093
-2.7%
0.00%
Q2 2023$2,214,075
-10.5%
140,934
-6.1%
0.00%
-100.0%
Q1 2023$2,473,974
+12.6%
150,120
+6.6%
0.00%0.0%
Q4 2022$2,196,817
+69.8%
140,822
+41.2%
0.00%
Q3 2022$1,294,000
+29.0%
99,718
+39.6%
0.00%
Q2 2022$1,003,000
+9.7%
71,445
+12.0%
0.00%
Q1 2022$914,000
+32.7%
63,801
+26.1%
0.00%
Q4 2021$689,000
-31.2%
50,596
-17.3%
0.00%
Q3 2021$1,002,000
-10.1%
61,166
-7.7%
0.00%
Q2 2021$1,115,000
-6.3%
66,248
+1.6%
0.00%
Q1 2021$1,190,000
-20.5%
65,191
-20.7%
0.00%
Q4 2020$1,496,000
-2.3%
82,173
-4.3%
0.00%
Q3 2020$1,531,000
-22.3%
85,840
-21.9%
0.00%
-100.0%
Q2 2020$1,971,000
-1.0%
109,884
-16.2%
0.00%0.0%
Q1 2020$1,991,000
-8.0%
131,195
+19.6%
0.00%0.0%
Q4 2019$2,164,000
+1.2%
109,701
-11.8%
0.00%0.0%
Q3 2019$2,139,000
-28.2%
124,393
-26.0%
0.00%0.0%
Q2 2019$2,978,000
-46.0%
168,188
-37.9%
0.00%
-50.0%
Q1 2019$5,517,000
+1219.9%
270,824
+990.1%
0.00%
Q4 2018$418,00024,8440.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2019
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders